These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6804245)

  • 1. Improved effect of glibenclamide on administration before breakfast.
    Sartor G; Lundquist I; Melander A; Scherstén B; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1982; 21(5):403-8. PubMed ID: 6804245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.
    Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
    Diabetologia; 1980 Jan; 18(1):17-22. PubMed ID: 6767639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
    Kigawa Y; Oba K; Futami-Suda S; Norose J; Yasuoka H; Suzuki K; Ouchi M; Watanabe K; Suzuki T; Nakano H
    Geriatr Gerontol Int; 2008 Sep; 8(3):160-5. PubMed ID: 18821999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behaviour of glibenclamide on repeated administration to diabetic patients.
    Balant L; Zahnd GR; Weber F; Fabre J
    Eur J Clin Pharmacol; 1977; 11(1):19-25. PubMed ID: 401739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of glibenclamide in diabetic patients during its routine clinical administration determined by a specific radioimmunoassay.
    Matsuda A; Kuzuya T; Sugita Y; Kawashima K
    Horm Metab Res; 1983 Sep; 15(9):425-8. PubMed ID: 6416980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients.
    Damsbo P; Clauson P; Marbury TC; Windfeld K
    Diabetes Care; 1999 May; 22(5):789-94. PubMed ID: 10332683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
    Groop L; Harno K
    Acta Endocrinol Suppl (Copenh); 1980; 239():44-52. PubMed ID: 6776763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation by previous nutrients of glibenclamide-induced insulin release in man. An effect which is counteracted by meal-induced retardation of drug absorption.
    Grill V; Efendić S; Regitz G
    Scand J Clin Lab Invest; 1986 Oct; 46(6):527-32. PubMed ID: 3095909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical application of the hypoglycemic agent glibenclamide and changes in blood glucose, plasma insulin (IRI) levels and plasma concentration of glibenclamide in normal rats.
    Yamamoto T; Katakabe K; Akiyoshi K; Kan K; Asano T; Okumura M
    Diabetes Res Clin Pract; 1990 Jan; 8(1):19-22. PubMed ID: 2105197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose, FFA, IRI and GH response to I.V. glibenclamide.
    Rastogi GK; Dash RJ; Sinha MK
    Horm Metab Res; 1973 Jul; 5(4):303. PubMed ID: 4199903
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of glibenclamide on the glucose and insulin profile in maturity onset diabetics following both acute and long term treatment.
    Owens DR; Biggs PI; Shetty KJ; Wragg KG
    Diabete Metab; 1980 Sep; 6(3):219-24. PubMed ID: 6777211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.
    Ward EA; Lang DA; Phillips MR; Turner RC
    Diabetes Care; 1981; 4(2):293-5. PubMed ID: 6783374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.
    Groop L; Wåhlin-Boll E; Groop PH; Tötterman KJ; Melander A; Tolppanen EM; Fyhrqvist F
    Eur J Clin Pharmacol; 1985; 28(6):697-704. PubMed ID: 3933984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of two doses of glibenclamide upon metabolic rhythms in maturity-onset diabetics.
    Nattrass M; Hinks L; Smythe P; Todd PG; Alberti KG
    Diabete Metab; 1978 Sep; 4(3):175-80. PubMed ID: 101402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects.
    Wåhlin-Boll E; Melander A; Sartor G; Scherstén B
    Eur J Clin Pharmacol; 1980 Oct; 18(3):279-83. PubMed ID: 7002565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
    Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
    Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glycemic/metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus.
    Ono Y; Nakamura A; Cho KY; Nomoto H
    Expert Opin Pharmacother; 2014 Feb; 15(3):311-24. PubMed ID: 24328511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man.
    Raptis SA; Hatziagelaki E; Dimitriadis G; Draeger KE; Pfeiffer C; Raptis AE
    Exp Clin Endocrinol Diabetes; 1999; 107(6):350-5. PubMed ID: 10543411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.